Prick or stick? new study tests home blood tests for diabetes care
NCT ID NCT06695325
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether people with diabetes can collect their own blood at home (using a finger prick or a device on the upper arm) to check blood sugar, cholesterol, and thyroid levels. The results will be compared to standard blood draws done by a nurse in the clinic. The goal is to see if home collection is accurate, easy for patients, and cost-effective, potentially reducing the need for clinic visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be identified and approached during a routine diabetes clinic service run by Tameside and Glossop Integrated Care NHS Foundation Trust, based at Ashton Primary Care. This is a single site study. Consent, randomisation and a venous and a capillary self-collected sample will be collected at Tameside and Glossop Integrated Care NHS Foundation Trust. A second capillary sample will be self-collected by the participant in an outside the clinic setting and posted to the central laboratory. Participants will complete a questionnaire in the clinic as well as outside the clinic. The outside the clinic questionnaire will be posted back to the research team at Tameside General Hospital.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult subjects aged 18 years and over at the time of signing the informed consent * Ability to provide Informed consent * Type I and II diabetic patient * Ability to understand written and spoken English * Ability to perform a blood draw at home Exclusion Criteria: * Aged less than 18 years of age * Unable to provide informed consent * Unable to perform a blood draw at home
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Tameside and Glossop Integrated Care NHS Foundation Trust
RECRUITINGAshton-under-Lyne, Lancs, OL6 9RW, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can coconut oil and moringa rinses fight gum disease in diabetic kids?
- Eye scans as a window to the body: study probes retinal imaging across diseases
- A routine blood count may reveal how severe diabetic ketoacidosis will be
- Smart pillbox aims to keep patients on track
- Can a glucose app that predicts lows calm diabetes fears?
- Can a toolkit help family doctors catch heart risk sooner?